DOLUTEGRAVIR | DOLUTEGRAVIR | ATC J05AX12 ATC J05AR21 ATC J05AR13 ATC J05AR25 ATC J05AR27
ANTIINFECTIVES HIV-1 ANTIVIRAL AGENT HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INTEGRASE STRAND TRANSFER INHIBITOR P-GLYCOPROTEIN SUBSTRATE | ORAL | Cmax 9.9 MICROMOLAR VD 17.4 LITER PPB 98.9 PERCENT Cl 1 LITER / HOUR HT 14 HOUR SOLUBILITY SLIGHTLY SOLUBLE IN WATER | HIV-1 INTEGRASE PDB 3S3O (CRYSTAL STRUCTURE OF THE PROTOTYPE FOAMY VIRUS (PFV) N224H MUTANT INTASOME IN COMPLEX WITH MAGNESIUM AND DOLUTEGRAVIR (S/GSK1349572)) LIGAND CODE = DLU (link to the list of PDB complexes) Download experimental 3D coordinates of DLU with added hydrogens | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE INHIBITOR CHEMBL3471 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE Q7ZJM1 INTEGRASE HUMAN IMMUNODEFICIENCY VIRUS 1 ENZYME HYDROLASE | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |